Key Insights

Highlights

Success Rate

78% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 42/100

Termination Rate

10.0%

2 terminated out of 20 trials

Success Rate

77.8%

-8.7% vs benchmark

Late-Stage Pipeline

30%

6 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed with results

Key Signals

78% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (3)
P 2 (1)
P 3 (2)
P 4 (4)

Trial Status

Completed7
Unknown6
Not Yet Recruiting3
Recruiting2
Terminated2

Trial Success Rate

77.8%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (20)

Showing 20 of 20 trials
NCT07514962Recruiting

Minimally Invasive Coronary Artery Bypass Supported by Cangrelor

NCT07398001Not ApplicableNot Yet Recruiting

Discontinuation of Antiplatelet Therapy After Drug-Coated Balloon Treatment

NCT07164859Phase 3Not Yet Recruiting

Safety and Efficacy of Very Short DAPT in Older Patients Undergoing PCI

NCT06710262CompletedPrimary

T-TAS® wS Method Comparison

NCT04624295Phase 4RecruitingPrimary

Early Antiplatelet Therapy After Hemorrhagic Infarction in Acute Ischemic Stroke Treated With Intravenous Thrombolysis (HITs)

NCT03987373Completed

DACAB Trial: Follow-up Extension

NCT06698874Not ApplicableNot Yet Recruiting

MCE Identifying Bleeding Lesions in Patients with Antiplatelet Drugs-Related Acute Non-Hematochezia Gastrointestinal Bleeding

NCT03908593Phase 4Unknown

Proton Pump Inhibitor Preventing Upper Gastrointestinal Injury In Patients On Dual Antiplatelet Therapy After CABG

NCT05554822Phase 3Unknown

Head-to-head Comparison of Single Versus Dual Antiplatelet Treatment Strategy After Percutaneous Left Atrial Appendage Closure: a Multicenter, Randomized Study

NCT03758248UnknownPrimary

The Influence of Gene Polymorphism on Clinical Outcomes in Patients Undergoing PCI

NCT03039205Phase 2Completed

Platelet Aggregation in Patients With Coronary Artery Disease and Kidney Dysfunction Taking Clopidogrel or Ticagrelor

NCT04060914Phase 4UnknownPrimary

LOwer Maintenance Dose TICagrelor in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention

NCT03224923Phase 4Terminated

A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY)

NCT03601013CompletedPrimary

Demographical and Clinical Profile of Patients on Dual Antıplatelet Therapy and Mean Precise-DAPT and DAPT Scores in Turkey

NCT03525145Unknown

Platelet Reactivity And Clinical ThrombotIC Events Study

NCT01810276Not ApplicableTerminated

Safety of Platelet Transfusion in Patients on Antiplatelet Therapy With Traumatic Head Injury

NCT02099422Unknown

Timing of Optimal Platelet Inhibition After Acute Coronary Syndrome

NCT01144819Completed

Platelet Inhibition in the Acute Phase of STEMI

NCT01647568Completed

Safety of Continuing Anti-platelet Agents During Colonoscopic Polypectomy: A Prospective Study

NCT01231035Completed

REsponsiveness to CLOpidogrel and Stent-related Events in Acute Coronary Syndromes (RECLOSE 2 - ACS)

Showing all 20 trials

Research Network

Activity Timeline